Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Inflammation is Scopus-indexed (Q1, CiteScore 9.3), WoS SCIE. Published by Springer.
Checked against the index lists dated .
ISSN 0360-3997Verify ISSN ↗1573-2576Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,790 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 42 / 234 | 82nd | Q1 |
| Immunology | 49 / 243 | 80th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present (also 1975–2005), best quartile Q1, CiteScore 9.3.
Inflammation is Q1 in Immunology and Allergy (rank 42 of 234) and Q1 in Immunology (rank 49 of 243), by CiteScore 2025.
Inflammation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.3, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.515, quartile Q1, with an H-index of 92.
The publisher lists an article processing charge of about US$4,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Inflammation is published by Springer. Its print ISSN is 0360-3997 and its online ISSN is 1573-2576.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Inflammation has an h-index of 107 and a 2-year mean of 5.22 citations per paper (OpenAlex). Its Scopus CiteScore is 9.3, quartile Q1. On 2-year citations it ranks #40 of 231 Scopus journals in Immunology and Allergy.
Inflammation published 176 papers in 2025; its busiest recent year was 2024 with 270. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (73.4%), Italy (4%) and India (3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 27 retracted papers are recorded (5.5 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.